These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27569943)

  • 1. Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant.
    Rodrigues Dos Santos BG; Amaral ES; Fernandes PF; Oliveira CM; Rodrigues JL; Perdigão Neto LV; Girão ES
    Transplant Proc; 2016; 48(6):2050-5. PubMed ID: 27569943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
    Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.
    Alevizakos M; Nasioudis D; Mylonakis E
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla
    Rosa R; Rudin SD; Rojas LJ; Hujer AM; Perez-Cardona A; Perez F; Bonomo RA; Martinez O; Abbo LM; Camargo JF
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
    de Maio Carrilho CM; de Oliveira LM; Gaudereto J; Perozin JS; Urbano MR; Camargo CH; Grion CM; Levin AS; Costa SF
    BMC Infect Dis; 2016 Nov; 16(1):629. PubMed ID: 27809803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
    Shendi AM; Wallis G; Painter H; Harber M; Collier S
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
    Lübbert C; Hau HM; Rodloff A; Mössner J; Mischnik A; Bercker S; Bartels M; Kaisers UX
    Z Gastroenterol; 2015 Nov; 53(11):1276-87. PubMed ID: 26562402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Asakura T; Ikeda M; Nakamura A; Kodera S
    Int J Infect Dis; 2014 Dec; 29():91-5. PubMed ID: 25461239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
    Kim SA; Altshuler J; Paris D; Fedorenko M
    Int J Antimicrob Agents; 2018 Jan; 51(1):155-158. PubMed ID: 28943367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
    Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
    Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome.
    Brakemeier S; Taxeidi SI; Zukunft B; Schmidt D; Gaedeke J; Dürr M; Hansen S; Budde K
    Transplant Proc; 2017 Oct; 49(8):1757-1765. PubMed ID: 28923621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EUropean prospective cohort study on
    Gutiérrez-Gutiérrez B; Sojo-Dorado J; Bravo-Ferrer J; Cuperus N; de Kraker M; Kostyanev T; Raka L; Daikos G; Feifel J; Folgori L; Pascual A; Goossens H; O'Brien S; Bonten MJ; Rodríguez-Baño J;
    BMJ Open; 2017 Apr; 7(4):e015365. PubMed ID: 28373258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
    Satlin MJ; Jenkins SG; Walsh TJ
    Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.
    Freire MP; Oshiro IC; Pierrotti LC; Bonazzi PR; de Oliveira LM; Song AT; Camargo CH; van der Heijden IM; Rossi F; Costa SF; DʼAlbuquerque LA; Abdala E
    Transplantation; 2017 Apr; 101(4):811-820. PubMed ID: 28009779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
    Barchiesi F; Montalti R; Castelli P; Nicolini D; Staffolani S; Mocchegiani F; Fiorentini A; Manso E; Vivarelli M
    BMC Infect Dis; 2016 Oct; 16(1):538. PubMed ID: 27716164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.